4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-099127
Chief Business Officer sold 2,705 shares at an average $45.12 ($122,054)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McNeill Jonathan Chief Business Officer | 2024-08-19 | Sale 10b5-1 | −2,400 | $45.01 | $108,024 | 132,411 | D |
| McNeill Jonathan Chief Business Officer | 2024-08-19 | Sale 10b5-1 | −305 | $46.00 | $14,030 | 132,106 | D |
| Open-market sales · 2,705 sh · avg $45.12 · $122,054 | |||||||
Loading xslF345X05/ownership.xml…